Resources with keywords: serology



Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses (NEW 8/3, Website, Publication)
JAMA
23 July 2021

Ilies Benotmane, Gabriela Gautier, Peggy Perrin, et al

SARS-CoV-2 Antigen Testing in Long Term Care Facilities (Website)
CDC

Considerations for Use in Nursing Homes and other Long-Term Care Facilities

ARCHIVED: Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020 (Website, Publication)
CDC/MMWR
4 September 2020

Self WH, Tenforde MW, Stubblefield WB, et al.

Reports on the infection rate of healthcare personnel.

ASM Serology Testing Webinar (Website)
American Society for Microbiology (ASM)

Amid the COVID-19 pandemic, many questions about serology testing have been asked by members of the clinical microbiology community. In this webinar, two expert panelists will answer your most frequently asked questions.

Independent Evaluation of SARS-CoV-2 Antibody Test Performance, FDA Data, 2020-2021 (Website, Regulatory)
CDC
24 February 2021

In collaboration with NCI, CDC, and BARDA, the FDA has developed a comprehensive dataset to compare the performance characteristics of different serological tests that were independently evaluated using well-characterized sample panels of positive and negative specimens for SARS-CoV-2 antibodies. 

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States (Website, Publication)
Science: Translational Medicine
31 January 2021

Kalish, H, Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med. 2021:13. DOI: 10.1126/scitranslmed.abh38

Kalish H, et al.
The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic

Go to Top